Cingulate Inc (CING) Directors and Executive Officers

Officers & Directors

Shane J. Schaffer
Chairman and Chief Executive Officer (Principal Executive Officer)

Bryan Lawrence
Director

Jennifer L. Callahan
Chief Financial Officer (Principal Financial Officer and Principal Accounting Officer)

Jeffrey S. Ervin
Director

John A. Roberts
Director

Peter J. Werth
Director ,

Cingulate Inc currently has 14 employees.

News about Cingulate Inc Key Personnel

Cingulate Inc. Seizes Growth Momentum: CEO Shane Schaffer Discusses ADHD Innovations Amid Financial Transformation on Big Biz Show,

In a significant development for Cingulate Inc. (NASDAQ: CING), a Kansas City-based biopharmaceutical company specialized in innovative drug delivery platforms, Shane J. Schaffer, Chairman and CEO, recently participated in the nationally syndicated Big Biz Show. During this broadcast, Schaffer provided insights into the company s leading asset, CTx-1301, which is currently undergoing Phase 3 trials for the treatment of Attention Deficit Hyperactivity Disorder (ADHD). CTx-1301 represents the forefront of Cingulate s pipeline, which utilizes its proprietary Precision Timed Release (PTR) technology—an innovative approach designed to optimize drug absorption and efficacy. In light of the increasing prevalence ...